Welcome to our dedicated page for Inspire Medical SEC filings (Ticker: INSP), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Inspire Medical Systems filings document formal disclosures for a medical technology company commercializing neurostimulation therapy for obstructive sleep apnea. Recent Form 8-K reports furnish quarterly and annual financial results, preliminary revenue information, Regulation FD presentation materials, tax-related events and officer or compensation matters.
Proxy and annual-meeting filings describe director elections, stockholder voting, executive compensation, equity incentive plan authorization and governance provisions, including charter and bylaw matters. These records also disclose common stock award reserves and the governance framework for a company selling Inspire therapy through hospitals and ambulatory surgery centers.
Inspire Medical Systems CEO Timothy P. Herbert reported equity awards and related tax withholding in company stock. He acquired 9,005 shares of common stock at $0.00 per share upon satisfaction of performance conditions tied to previously granted performance stock units. To cover taxes on this vesting, 4,010 shares were disposed of at $59.53 per share through share withholding, a non‑open‑market transaction. Herbert also received an award of 62,153 restricted stock units that will vest in three equal annual installments starting on February 20, 2027, each representing one share of common stock if he remains employed through the vesting dates. Following these transactions, he held 37,681 shares directly, and 63,658 shares were held indirectly by a family trust.
Inspire Medical Systems officer Bryan K. Phillips reported equity awards and related tax withholding transactions in company stock. He acquired 2,400 shares of common stock at no cost upon satisfaction of performance conditions tied to previously granted performance stock units and had 735 shares withheld at a price of $59.53 per share to cover taxes on that vesting. He also received two additional stock-based awards: 15,958 shares credited in connection with performance awards and 8,399 restricted stock units that will vest in three equal annual installments starting on February 20, 2027, subject to continued employment.
Inspire Medical Systems, Inc. reported that company officer Jason P. Kelly received an award of 15,958 shares of common stock in the form of restricted stock units. The award was granted at no cash cost.
The RSUs vest in three equal annual installments starting on February 20, 2027, and each unit converts into one share of common stock if Kelly remains continuously employed through the applicable vesting date. Following this grant, he directly holds 19,948 shares of Inspire Medical Systems common stock.
Inspire Medical Systems reported that Chief People Officer Melissa Mann acquired 15,958 shares of common stock through a grant of restricted stock units. These RSUs vest in three equal annual installments starting on February 20, 2027. Each RSU converts into one common share if she remains employed through each vesting date.
Inspire Medical Systems executive Weatherby Carlton reported equity compensation changes involving the company’s common stock. On February 20, 2026, he acquired 2,196 shares at no cost following satisfaction of performance conditions on previously granted performance stock units, and 672 shares were withheld at $59.53 per share to cover taxes on that vesting.
On the same date, he also received additional stock awards totaling tens of thousands of shares at no cost, including restricted stock units that vest in three equal annual installments beginning February 20, 2027, contingent on his continued employment. After these transactions, his directly held common stock balance increased, even after the tax-withholding disposition.
Inspire Medical Systems officer John Rondoni reported equity compensation and related tax withholding in company stock. He acquired 2,400 shares of common stock at no cost upon satisfaction of performance conditions tied to earlier performance stock units, and 15,958 additional shares through a new stock award.
To cover taxes from vesting of a performance stock unit award, 735 shares were withheld at a price of $59.53 per share. After these transactions, he directly owned 14,548 shares following the tax withholding and 30,506 shares following the new restricted stock unit award, which will vest in three equal annual installments starting February 20, 2027.
Inspire Medical Systems, Inc. chief financial officer Matthew J. Osberg has filed an initial ownership report showing his equity stake in the company. The Form 3 lists direct ownership of 19,794 shares of common stock. A noted portion represents restricted stock units that vest in three equal annual installments starting on January 31, 2027, with each unit convertable into one share of common stock if he remains employed through the vesting dates.
Inspire Medical Systems interim CFO Richard Buchholz disposed of 579 shares of common stock at $59.76 per share to cover taxes due on the vesting of a restricted stock unit award. After this tax-withholding disposition, he directly holds 43,988 shares and indirectly holds 1,475 shares through his son.
Inspire Medical Systems, Inc. CEO and President Herbert Timothy P. Herbert reported a tax-withholding disposition of 1,635 shares of common stock at $59.76 per share. These shares were withheld by the company to satisfy taxes related to the vesting of a restricted stock unit award.
After this transaction, he directly holds 32,686 common shares. An additional 63,658 shares are held indirectly through the Timothy P. Herbert 2018 Family Continuation Trust c/u the Timothy P. Herbert 2018 Grantor Retained Annuity Trust.
Inspire Medical Systems, Inc. Chief People Officer Melissa Mann reported a Form 4 showing a tax-related share disposition. The company withheld 615 shares of common stock at $59.76 per share to satisfy taxes due upon vesting of a restricted stock unit award. After this withholding, she directly holds 7,651 common shares.